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ABSTRACT
Tobacco is the largest single cause of premature death in the developed world. Two
methods of estimating the number of deaths attributable to smoking use mortality from lung
cancer as an indicator of the damage from smoking. We reestimate the coefficients of one of
these, the Preston/Glei/Wilmoth model, using recent data from U.S. states. We calculate smoking
attributable fractions for the 50 states and the U.S. as a whole in 2000 and 2004. We estimate
that 21% of adult deaths among men and 17% among women were attributable to smoking in
2004. Across states, attributable fractions range from 11% to 30% among men and from 7% to
23% among women. Smoking related mortality also explains as much as 60% of the mortality
disadvantage of Southern states. At the national level, our estimates are in close agreement with
those of the Centers for Disease Control (CDC) and Preston/Glei/Wilmoth, particularly for men.
But we find greater variability by state than does CDC. We suggest that our coefficients are
suitable for calculating smoking-attributable mortality in contexts with relatively mature
cigarette smoking epidemics.
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INTRODUCTION
Tobacco is the largest single cause of premature death in the developed world and is
growing in importance throughout the developing world. At the individual level, cigarette
smoking is strongly linked to lung cancer; but smoking also confers increased risk of death from
other cancers, heart diseases, stroke, and chronic respiratory conditions (Doll et al. 2004).
Although the CDC estimates that as many as 400,000 deaths annually in the United States are
attributable to cigarette smoking, only about 30% of these deaths are caused by lung cancers
(CDC 2008; Mokdad et al. 2004).
Cohort studies demonstrating the link between cigarette smoking and individual mortality
track the mortality of individuals according to their smoking behavior. The prospective study of
British doctors beginning in 1951 (Doll et al. 2004) and the American Cancer Society’s Cancer
Prevention Studies (CPS) Cohorts I and II, beginning in 1959 and 1982, respectively, provide
rich data on the excess risks associated with cigarette smoking from a number of causes of death.
A second approach to estimating the amount of excess mortality attributable to smoking
uses lung cancer mortality, rather than survey data, as the indicator of smoking. The most
widely-known of these “indirect” approaches was designed by Peto, Lopez and colleagues (Peto
et al. 1992). It uses the death rate from lung cancer as an indicator of the accumulated damage
from smoking and combines that indicator with estimates of the relative risk of smokers
compared with non-smokers of mortality from certain disease categories. Preston, Glei, and
Wilmoth (PGW, 2010a) recently developed another indirect method which relies on the
statistical relationship between lung cancer and all other causes of death that was estimated
across countries and time periods. Preston, Glei, and Wilmoth (2010b) and Rostron (2010) use
virtually the same data set but introduce small modifications of the estimation equation that
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produce small changes in estimated attributable deaths for males but sizeable reductions for
women above age 80. A recent report of the National Research Council (2011) relies upon the
results of PGW (2010b) to conclude that international differences in smoking-attributable deaths
are the principal explanation of shortfalls in life expectancy at age 50 in the United States
relative to other OECD countries.
This paper has one substantive goal and one methodological goal. The substantive goal
is to provide improved estimates of the extent to which smoking explains state inequality in adult
life expectancy in the most recent time period. Available data indicate that states differ
substantially in both all-cause mortality as well as in the prevalence of smoking among adults.
The maps in Figure 1 present the patterns in 2004. Southern states exhibit considerable
disadvantage with respect to mortality as well as relatively high rates of smoking in the
population. Alternatively, states in the West and Northeast show low mortality and relatively
low prevalence of smoking. Lung cancer mortality rates have also tended to follow a similar
pattern, relatively high in the South and quite low in the West (Devesa et al. 1999). These
patterns suggest that smoking may play an important role in accounting for the regional patterns
of life expectancy within the United States. We intend to evaluate this linkage more precisely
than has been done previously.
The methodological goal is to provide a test of the new PGW method on a new data set.
To date, the three papers that use the basic PGW approach (Preston et al. 2010a; 2010b; Rostron
2010) have estimated the coefficients of the relation between all-cause mortality and lung cancer
mortality on a data set pertaining to 20 or 21 countries over the period 1950-2006. If the
approach is generalizable, the estimated relation should be much the same when different units
of analysis are used. We reestimate the coefficients of the PGW model using data from US
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states rather than international data. We use the results to calculate smoking-attributable
mortality in the United States in 2004. We integrate the methodological and substantive goals in
comparing our results for individual states and the U.S. as a whole to those of other methods for
estimating smoking attributable-risk.
Methodological Approaches to Calculating Smoking Attributable Risk
Studies calculating excess mortality due to cigarette smoking typically use an
attributable-risk approach; they estimate the number of deaths that would not have occurred if
smokers had experienced the same death rates as non-smokers (Peto et al. 1994). This calculation
requires information about the increased risk conferred upon smokers by their behavior as well
as information about the prevalence of smoking in the population. Two broad sets of methods
have been developed and applied in a variety of different settings.
The first set of methods could be termed direct methods, because the mortality
differential between smokers and non-smokers is directly observed. These studies require
detailed data on the smoking behavior and mortality experience of cohort members followed
over a number of years. In the United States, the most commonly cited study is the American
Cancer Society Cancer Prevention Study Cohort II (CPS-II) which is composed of more than 1.2
million individuals followed from 1982 through 1988. The Centers for Disease Control and
Prevention (CDC) issues regular estimates of smoking-attributable mortality in the U.S. using
relative risks from CPS-II (Adhikari et al. 2009) and estimates of smoking prevalence from the
National Health Interview Survey (NHIS) or from the Behavioral Risk Factor Surveillance
System (BRFSS). Based on excess mortality among current smokers and former smokers relative
to non-smokers, they calculate mortality attributable to cigarette smoking by applying relative
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risks to current smoking status data. They find that 440,000 annual deaths can be attributed to
cigarette smoking in the early 2000s, more than one-fifth of all adult mortality.
The CDC approach been criticized on several grounds. First, the cohorts used to provide
the relative mortality risk of smokers are not representative of the U.S. population (Thun et al.
1997). Second, the CDC assumes that the relative mortality level of smokers compared to nonsmokers reflects only the effects of smoking, an assumption that ignores other behavioral and
socioeconomic factors with which smoking may be correlated. Rogers et al. (2005) use the NHIS
1990 supplement to control for many such confounders, which decreases the estimated number
of smoking-attributable deaths in the year 2000 to 338,000. Third, smoking behavior categories
recorded at baseline do not reflect temporal changes in cohort smoking patterns, and many
studies assume that baseline smoking status remains constant throughout the study; estimated
risks will be attenuated if there are any changes during the period of observation. Finally, largescale cohort studies require long periods of data collection and detailed demographic information
that is unavailable for many relevant populations.
As noted above, Peto, Lopez, and colleagues (1992) developed another type of method
that instead calculates the ‘impact’ of smoking indirectly from the lung cancer death rate in the
population rather than through direct observation. Assuming that smoking behavior is the only
factor which increases the risk of lung cancer death of smokers relative to non-smokers, they use
CPS-II non-smoker lung cancer death rates to calculate age-specific ‘proportion exposed’ that
reflects the prevalence of smoking-related damage. They then import relative risks for various
disease categories from CPS-II and apply them to this ‘proportion exposed’ in the population of
interest. In order to correct for confounding, they decrease the relative risks from causes of death
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other than lung cancer by half. The method has been used to produce estimates of smoking
attributable mortality for developed countries for the year 2000 (Peto et al. 2006).
PGW (2010a) developed an alternative method to Peto-Lopez which makes fewer
assumptions and does not rely heavily on the generalizability of CPS-II relative risks. They
develop a model estimating the statistical relationship between the lung cancer death rate and the
death rate from other causes of death across developed countries between 1950 and 2006. This
relation is then used to estimate the mortality impact of smoking on causes of death other than
lung cancer. They use lung cancer death rates of non-smokers in CPS-II between 1982 and 1988
(Thun et al. 1997) to produce an estimate of lung cancer attributable-risk for each population of
interest. The method produces results that are similar to those of Peto-Lopez while avoiding
strong assumptions and a complex implementation procedure.
The key similarity of the two indirect methods, Peto-Lopez and PGW, is that the lung
cancer death rate is interpreted as an indicator of the damage from smoking within a population.
Lung cancer is a unique condition because it is so closely tied to one behavioral risk factor.
While other causes of death are linked to smoking behavior, none is related as strongly as lung
cancer. In CPS-II, smoking was responsible for more than 90% of lung cancer deaths among
men and more than 70% among women (Thun et al. 1997). Since lung cancer mortality reflects
current and past prevalence as well as intensity of cigarette smoking in a population, it is likely
to be a more reliable measure of smoking’s population-level impact than are direct cohort data
derived from a single-round survey (Peto et al. 1992). The use of the lung cancer death rate in
this way is further justified by evidence that differences in lung cancer mortality across place and
time result almost exclusively from variation in cigarette smoking (see Preston et al. 2010b for a
discussion of these issues).
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State Variation in Mortality in the United States
Geographic differences in mortality have been particularly longstanding within the
United States (Devesa et al. 1999). States in the South region are at a clear disadvantage
compared with their counterparts in other parts of the country (Figure 1). The cluster of highmortality states in the South is striking, and in fact the 12 states with the highest death rates are
geographically contiguous. According to vital statistics, these states exhibit all-cause death rates
that are 30-40% higher than those of the low mortality states, which translates into around 4-5
years difference in life expectancy at birth. States that perform relatively well are slightly more
dispersed; low-mortality pockets occur in the Upper Midwest (e.g. Minnesota, North Dakota),
New England (Connecticut, Vermont), Mountain West (Arizona, Colorado), and Pacific
(California, Hawaii). Although there have been some long-term changes in the size of state-tostate disparities in adult mortality (NCHS 1991), the general pattern of southern disadvantage has
been remarkably stable over time.
The experience of the United States with respect to the smoking epidemic has been
somewhat exceptional in comparison to its European counterparts. Smoking began early and
remained quite heavy until relatively recently when the US experienced drastic declines in
cigarette use (Forey et al. 2002). American women have shown particularly high rates of
smoking compared to women in Europe, and the mortality burden of smoking is accordingly
high among women in the United States (Peto et al. 2006). But large regional differences in
cigarette smoking behavior and related mortality exist within the US (CDC 2009). The Southern
states have the greatest numbers of smokers while states in the West and Northeast have few.
Despite declining rates of cigarette smoking in the United States, many Southern states continue
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to exhibit relatively high smoking prevalence (e.g., 30% in Kentucky compared with 10-17% in
the West).
We merge our methodological with our substantive goal in applying the PGW model to
US states. We reestimate the coefficients of the PGW model (Preston et al. 2010b) using annual
mortality data at the U.S. state level between 1996 and 2004. Based on the results of this
estimation, we calculate smoking-attributable mortality for the United States as a whole as well
as for the fifty states and demonstrate the impact of smoking-related mortality on state-specific
patterns of mortality in the U.S. Finally, we compare attributable fraction estimates for the U.S.
produced by a variety of methods.
DATA
We use vital statistics data on deaths for the fifty states annually between 1996 and
2004.1 Death data are available through the Multiple Cause-of-Death (MCD) public-use microdata files released annually by the National Center for Health Statistics (NCHS). MCD files
contain demographic, geographic, and cause-of-death information about all deaths occurring in
the United States. Population denominators for death rate calculations come from bridged-race
files available from the NCHS.2 Deaths are based on state of residence, rather than state of
occurrence. There is little evidence that migration has a noticeable effect on geographic mortality
patterns (Ezzati et al. 2008).
METHOD
Statistical Model
Following Preston et al. (2010a) we estimate the relationship between the age-specific
lung cancer death rate and the log of the death rate from other causes of death annually between
1

2004 is the latest year for which geographic identifiers below the national level are available in the public-use
version of the MCD files.
2
Electronically from http://www.cdc.gov/nchs/nvss/bridged_race.htm, accessed May, 2009.
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1996 and 2004. We use negative binomial regression to predict the log the of death rate from
causes other than lung cancer in five-year age groups from 50 – 54, 55 – 59, …, 80 – 84 as a
function of the death rate from lung cancer
ln    





 

  





(1)

where  and  are the death rate for lung cancer and other causes respectively in each state,
year, and five-year age group.

and

, are dummy variables for age-group and state

respectively, while  and  are their corresponding coefficients. We include a linear time trend
(T) as well as interactions between lung cancer mortality and age-group. e is a random
disturbance term. In contrast to Preston et al. (2010b), we do not include interactions between
lung cancer and time nor between state and time. The time period considered here is relatively
short compared with that in PGW, and we do not expect substantial changes in the relationship
between lung cancer and other causes over this period. We consider the impact of our choice of
years on the estimated attributable fractions in our sensitivity analyses (below). We use agespecific population size as a statistical “offset” to control for exposure to mortality. We estimate
separate models by sex to allow for distinct relationships between smoking and mortality for men
and women. The coefficients of interest are  and  , denoting the age-specific relationship
between lung cancer and other causes of death (   

 ), which are used to calculate the

attributable fraction.
Preston, Glei, and Wilmoth have produced two sets of coefficients using the model: one
which drops observations for age 85+ and one which maintains them (Preston et al. 2010a,
2010b). Data for this age group were subject to age misreporting and, as an open-ended interval,
to extraneous influences resulting from differences in age distributions. These effects had
produced a set of parameters that were implausible at the oldest ages. Dropping these
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observations produced a smoother sequence of coefficients at older ages and reduced the fraction
of deaths attributable to smoking among older women. The current estimation also drops data for
ages 85+ and uses the results of PGW (2010b) for ages 50-84 in comparisons reported below.
Attributable Risk Calculation
Lung cancer deaths attributable to cigarette smoking are estimated using values of lung
cancer death rates among never-smokers, reported by Thun et al. (1997) from the CPS-II study
between 1982 and 1988. The proportion of lung cancer deaths attributable to smoking is the ratio
of smoking-related lung cancer death rate to the overall lung cancer death rate
  
 

where  is the lung cancer death rate among lifelong non-smokers, the expected death rate in
the absence of smoking. While lung cancer mortality among never smokers does show some
variation across populations (Thun et al. 2008), there is little evidence for long-term changes
across periods (Rosenbaum, Sterling and Weinkam 1998).
Following Preston, Glei, and Wilmoth (2010b), we calculate mortality attributable to
smoking for causes of death other than lung cancer based on the relationship between lung
cancer and other causes across states. The proportion of deaths from other causes attributable to
smoking is found by comparing the actual number of deaths from other causes to the number that
would be expected if mortality from lung cancer were set at the level for never-smokers. Given
the model, this estimate is found by
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where   is the model coefficient for lung cancer including age interactions (   

 ).

The attributable fraction3 for total mortality is a weighted average of the attributable fractions for
lung cancer and other causes


 

 


where  and  are deaths from lung cancer and other causes respectively and  is total deaths.
In their application, Preston et al. (2010a) find that the estimated attributable fraction is generally
robust to alternative specifications of age, time period, and interactions. We calculate standard
errors for our attributable-fraction estimates by resampling within the parameter distributions.
We simulate 1,000 sets of   coefficients, allowing them to vary based on the estimated
variance-covariance matrix from the regression procedure. These simulated coefficients produce
an artificial sample of attributable fractions for each state which allows us to calculate the
standard error. We report 95% confidence intervals in Appendix Table A.1.
Variation in Mortality by U.S. State
We estimate smoking-attributable mortality for ages 50-84 for the United States as well
as the fifty states. We calculate the expected number of years lived in this age range and ageadjusted death rates both including and excluding smoking-related deaths. Age-specific death
rates in the absence of smoking (

 )

include only those deaths not attributed smoking by our

model


3





  


Since the lung cancer death rate is the chief input for the calculation of the attributable fraction, the correlation
between the age-adjusted lung cancer death rate and the attributable fraction across states is very high (0.97 among
women, 0.99 among men). The attributable fraction is a more meaningful measure of the burden of smoking than
simple lung cancer mortality since it accounts for various other causes of death for which smoking is a risk factor
(Preston et al 2010a).
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where  the number of deaths attributed to smoking and P is the number of person-years of
exposure. We then recalculate life tables and age-adjusted mortality for each state with smokingrelated deaths removed.4
RESULTS
Figure 2 shows the age-pattern of lung cancer mortality for men and women in the United
States for ages 50-84. The death rate rises with age for both sexes, with men experiencing
substantially higher death rates than women at all ages. These death rates reflect the
accumulated damage from smoking for the cohorts in each respective age group in the United
States.
Table 1 presents estimated coefficients from the model in Equation 1. If exponentiated,
they can be interpreted as the proportional increase in the death rate of causes other than lung
cancer associated with an increase in the lung cancer death rate of one per thousand, all else
being equal. Coefficients are smaller at higher ages, reflecting both higher death rates overall and
more varied factors influencing mortality. Lung cancer death rates for the US population in 2004
and among lifelong non-smokers from CPS-II are presented in Table 2. Given that we assume
smoking to be the sole source of population variation in lung cancer death rates, the non-smoker
rates in Table 2 are intended to represent conditions in which smoking were eliminated. The
difference between these rates and observed lung cancer rates is used to calculate lung cancer
attributable-risk. As shown in Table A.1, we estimate that smoking was responsible for 21% of
deaths among men and 17% among women aged 50-84 in the U.S. in 2004. The maps in Figure
3 display estimated attributable fractions by state for females and males, respectively. Darker
shades represent a greater proportion of attributable deaths. For both sexes there is substantial
4

We elect to simply ‘remove’ smoking deaths from the life table calculation as opposed to using ‘cause-deleted’ life
tables in order to preserve the simplicity of interpretation. The results do not change substantively.
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geographic variation in the burden of smoking-attributable mortality (Figure 3 and Table A.1.).
The highest attributable fractions among women are found in Alaska, Kentucky, and Nevada
(around 22%), states notorious for relatively high rates of smoking among women (CDC 1996;
Remington et al. 1989). The lowest fractions are found in Utah, New Mexico, and Hawaii. Utah
has an exceptionally low mortality burden, with only 7% of deaths attributed to smoking in 2004.
Among men, there is a strong concentration of smoking-related mortality in the Southern states.
Kentucky, Mississippi, and Tennessee all exhibit attributable fractions close to 30%. States in the
Mountain West like Utah, New Mexico, and Colorado have fractions lower than 15%.
To estimate the extent to which smoking explains variation in life expectancy across
states in the United States we compare variance in state-specific age-adjusted mortality before
and after removing smoking-related deaths. The proportional reduction in variance represents the
fraction explained by smoking-related mortality. We find that smoking accounts for 35% of state
variation in mortality among women in 2004. Among men, it is even more important, explaining
65%. The sex difference reflects greater overall importance of smoking as well as a stronger
correlation with state-specific mortality experience among men. Differences in smoking patterns
are evidently a huge source of variance in life expectancy among states.
To assess more specifically the role of smoking in the very high mortality in the South,
we compare the mortality experience of the South relative to other regions in the presence and
absence of mortality related to smoking. Table 3 reports the proportion of the Southern
disadvantage that is attributable to smoking. High mortality related to smoking is an important
factor in each regional comparison. For women, it explains 18-20% of the Southern
disadvantage relative to the Pacific states, the Central Midwest, and the Northeast, 25% relative
to the Upper Midwest, and 35% relative to the Mountain states. Smoking is responsible for 23%
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of the difference between the Southern states and all states outside the South. Among men,
smoking-attributable mortality is even more important. It explains 43-48% of the disadvantage
relative to the Pacific states, and the Central and Upper Midwest, 50% relative to the Northeast,
and 60% relative to the Mountain. Overall, we estimate that the difference in male mortality
between the South and all other states would be cut in half in the absence of smoking.
Sensitivity Analyses
Our data apply to very recent years, in order to produce estimates that best reflect the
mortality burden of smoking in the current stage of the smoking epidemic in the United States.
PGW estimations cover a much longer time period and introduce a linear trend in the coefficient
relating lung cancer mortality to mortality from other causes and in country coefficients. To see
whether their approach would change our results, we perform the above analyses using data for
the period 1970 – 2004 and include interactions between lung cancer and year and between state
and year in order to capture changes in the impact of smoking that occur over the longer period.
We find that this model produces attributable fractions virtually identical to those from the
original model, indicating that our estimates are not sensitive to the length of the period
considered or to the treatment of trends. This specification produces attributable fractions of 0.21
for men and 0.17 for women for the U.S. as a whole in 2004, identical to the fractions produced
by the model without time trends.
Additionally, to ensure that our results are not driven by state differences in racial
composition, we estimate parameters of our basic model using exclusively data on the white
population. The estimated attributable fractions are slightly lower than those for the total
population, but attributable fractions for the white population are correlated with those for the
total population at 0.95 for men and 0.99 for women.
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COMPARISON WITH ALTERNATIVE METHODS
Researchers have developed a number of methods for estimating the number of deaths in
a population attributable to cigarette smoking. Table 4 shows estimated smoking-attributable
fractions for the United States using six different procedures. The first row shows estimates of
smoking-attributable fraction for U.S. men and women in 2000 and 2004 using the present
procedure. Row 2 shows estimates obtained using coefficients found by PGW (2010b) using the
same estimation model with different coefficients estimated across a sample of 21 developed
countries. Their attributable risk estimates for ages 50-84 are very similar to ours, especially for
men. Their estimates for women are somewhat higher (0.20 vs 0.17). Row 3 presents estimates
from Rostron’s (2010) modification of the PGW estimation procedure. Again, male estimates are
very similar but female estimates are lower than ours. Some of the disparity is a result of the
inclusion of ages 85+ in the Rostron estimates but not in ours, since he finds a low attributable
risk above age 85. Row 4 shows estimates using the Peto-Lopez method reported in Peto et al.
(2006) for ages 35+, which are somewhat higher than ours. Estimates from the CDC (Row 5) are
slightly higher than ours for men (0.24) and lower among women (0.15). The estimates made by
Rogers et al. (2005) (Row 6) using smoking-status data from the NHIS are substantially lower
than our estimates for females (0.13) and quite similar to ours for males (0.21). As noted earlier,
relative risks derived from baseline smoking data would be downwardly biased if status at
baseline is misclassified or if changes in smoking status occurred during the seven-year followup period. Both the Rogers et al. (2005) and CDC estimates suffer from this limitation.5
Table 4 indicates that there is considerably more uncertainty about estimates for women
than estimates for men. The male attributable fractions in the Table have a range of only 0.03,
5

However, CDC estimates use the current prevalence of smoking to make attributable-risk estimates, which does
not accurately reflect the mortality burden of smoking. However, depending on yearly changes in the prevalence of
smoking, this may offset some of the downward bias from the use of baseline relative risks.
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whereas the range for women is 0.08. Estimates based on smoking behavior (CDC and Rogers et
al.) occupy the lower end of the range for women. The current estimates are in the middle of the
range. We can also compare our estimates to state-specific estimates made by the Center for
Disease Control (2009). CDC estimated smoking prevalence at the state level from the
Behavioral Risk Factor Surveillance Survey (BRFSS). This data source is based on telephone
surveys and has a response rate that differs by state, in part because states have control over how
the BRFSS is executed (e.g., with respect to questionnaire length, whether data collection is inhouse or contracted out, and sampling design) The national response rate in 2004 was 52.7%
(Schneider and Lapane 2007). CDC combined these estimated prevalences with estimates of the
proportion of deaths from various causes that is attributable to smoking, estimates that were
drawn from deaths for 1982-88 (CDC 2009). Data used in the CDC estimates is thus somewhat
dated and subject to reporting biases.
Despite considerable differences between our method and that of CDC, the geographic
patterns implied by both methods are relatively consistent across states. Figure 4 shows the
comparability of CDC (2009) state-specific attributable risk estimates for the period 2000-2004
and those based on our method for 2004. The correlation between the two series is a relatively
high 0.81 for both males and females. However, CDC’s estimates are consistently lower than
ours for women and higher for men. These discrepancies may reflect the crudeness of the CDC
method, specifically its effort to model the mortality impact of smoking through contemporary
surveys of smoking status and its uses of dated estimates of the relative risk of smoking. The
relative mortality risk of smoking depends on duration (number of years smoked), intensity
(number of cigarettes per day), inhaling practices, and type of cigarette (Flanders et al. 2003).
As the composition of smokers changes over time, so does the observed relative risk of death
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among smokers (Thun et al. 1997). This risk rose between the American Cancer Society’s
Cancer Prevention Studies I and II (Thun et al. 1995) and also during the major study of British
doctors (Doll et al. 2004). CDC uses relative risks estimated in the CPS-II for current and former
smokers during the period 1982 – 1988. Unpublished analyses of NHIS data by Mehta and
Preston (2011) indicate that the relative risk of death among smokers has continued to rise
among women since 1988, which may account for an underestimate of smoking effects among
women by CDC. Because of the lag between smoking behavior and mortality outcomes,
smoking prevalence may say more about the burden of smoking in the future than in the current
period (Peace 1985; Preston et al. 2010a).
METHODOLOGICAL IMPLICATIONS AND LIMITATIONS
The PGW model, unlike the approach used by the CDC and by Peto and Lopez (1992),
does not borrow relative risk estimates from prospective studies of smokers and non-smokers. It
uses lung cancer mortality as an indicator of the damage from smoking and assumes that such
damage can be identified in other causes of death by modeling the relation between lung cancer
mortality and mortality from other causes. Parameters of that model have been estimated using
international and intertemporal data in PGW (2010a, 2010b) and in Rostron (2010).
The present paper applies the PGW model to recent cross-state data in the US.
Coefficients for males and females from the current estimation and from PGW (2010b) are
presented in Table 1 and graphed in Figure 5. Several patterns are clearly evident:
1) The sets of coefficients estimated on the basis of data in the contemporary US are
quite similar for men and women, suggesting that lung cancer mortality is functioning
in the US as stable indicator of the incremental mortality risk, presumably associated
with smoking, for other causes of death. On the other hand, female coefficients are
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much larger than male coefficients in the international data set investigated by PGW
(2010b) and Rostron (2010). No explanation of this sex difference has been provided.
2) Male coefficients estimated using US data are remarkably similar to those estimated
from the international/intertemporal data. This similarity provides an encouraging
indication that the overall approach to estimating the impact of smoking is reliable for
males.
3) The outlier series is the set of coefficients for females estimated from the
international/intertemporal data. Coefficients for this series are generally higher than
those from the other three series, and substantially so at younger ages.
We suspect that the high coefficients for women in the PGW (2010b) series are a result of
the recency of the smoking epidemic for women in their data set. The data set begins with
observations from the early 1950’s for all 21 countries. In most of these countries, few older
women were smoking during that era. PGW’s (2010a) estimates of attributable risk from
smoking for women in 1955 are above 0.01 in only two of 21 countries. In contrast, the median
value for males was already 0.07 by 1955.
The maturity of the smoking epidemic may, for example, affect the relation between lung
cancer mortality and mortality from other causes of death by virtue of different lags in the
relation between smoking and different causes of death. It is possible that the damage inflicted
by smoking takes longer to manifest itself in mortality from lung cancer than from other causes
of death. If so, this different pattern of lags would explain why the coefficient relating mortality
from other causes to that from lung cancer is higher among newly-smoking countries than in the
US, connoting fewer excess lung cancer deaths per excess death from other causes. Support for
this possibility comes from a comparison of relative risks of death between CPS I (1959-65) and
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CPS II (1982-88). The relative risks of death from lung cancer among female smokers compared
to non-smokers rose dramatically from 2.7 in the former to 12.8 in the latter (Thun et al. 1995).
The increases for coronary heart disease (1.4 to 1.8) and for “other smoking-related cancers” (1.8
to 2.6) were much smaller.
The US has a relatively mature smoking epidemic among both men and women (Forey et
al. 2002; Pampel 2010). In contrast to the data used by PGW, our sample of geographic units is
relatively homogeneous with respect to the stage of the epidemic.6 Thus we do not expect any
noticeable distortion resulting from state-to-state variation in the maturity of the epidemic since
smoking is longstanding throughout the United States. We suggest that the US coefficients for
women from the current estimation in Table 1 may be more appropriate for countries such as the
US with a mature tradition of women’s smoking, whereas the PGW estimates for women may be
more appropriate for relative newcomers. Indeed, our coefficients imply an attributable fraction
that is slightly lower than that given by PGW. Yet the difference is relatively small because
women’s coefficients become closer at ages 70-85 where deaths are heavily concentrated. And of
course lung cancer deaths are treated the same way in both methods. For men, the choice
between the two series is basically immaterial because they are so similar to one another.
Our analysis has several limitations. First, we use mortality data only from the most
recent period, unlike PGW who investigate data from 1950-2006. Since our focus is on the
burden of smoking-related mortality across US states during the current period, we chose to
include only the previous 10 years. Our sensitivity analysis indicates that our estimates do not

6

In the PGW sample, lung cancer death rates among men range from less than 3 to more than 40 per 10,000. This
compares with a range between 12 and 34 per 10,000 in states in our estimation. Among women, rates in the PGW
sample range from 4 to more than 140 per 100,000 compared with a range between 60 and 190 per 100,000 among
states. Furthermore, the variance in lung cancer mortality is nearly 4 times as large in the PGW sample as in our
sample among men and nearly twice as large among women.
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change when we include data for the period 1970 – 2004, which connotes considerable
robustness for the present estimates.
The second limitation is our assumption that, in the absence of smoking, individuals
would have the death rate from lung cancer recorded among lifelong never smokers in the CPSII. Although smoking is the primary factor driving differences in lung cancer mortality over time
and space, we cannot be certain that never-smoker death rates are the same across states.
Research by Thun and others suggests, for example, that non-smoker lung cancer rates are quite
different in Asian and non-Asian populations (Thun et al. 2008). However, because smoking has
been found to cause the vast majority of lung cancer deaths in heavy-smoking populations
(Ezzati and Lopez 2003), slight differences in the non-smoker rates will not greatly affect our
conclusions regarding the level or geographic pattern of the burden of smoking.
Third, we are unable to completely account for the consistent differences between our
results and those of CDC for states. It is likely that the discrepancies primarily reflect the
crudeness of CDC’s procedure and the drawbacks of direct methods described previously. In the
absence of ideal cohort smoking data, each method must some assumptions about the
relationship between smoking and mortality at the individual level. CDC assumes that all
current smokers have the same mortality risk, and applies this risk the observed smoking status
composition of each state population. PGW uses the lung cancer death rate as an indicator of the
accumulated damage from smoking in the population and assumes a constant relationship (in the
form of the coefficients) between mortality from lung cancer and mortality from other causes.
Fortunately, both methods identify approximately the same geographic pattern of smokingrelated mortality.
CONCLUSION
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Despite recent declines in the prevalence of smoking in many developed countries
including the United States, the mortality burden of smoking remains large among both men and
women. The US has been characterized by early onset of the smoking epidemic and by
relatively heavy smoking in comparison to many European countries. At the same time, data
have suggested that individual states differ greatly in the prevalence of smoking as well as
mortality from smoking-related cancers. One goal of this paper was to apply the recently
developed PGW model to data from the United States in order to provide detailed estimates of
the contribution of smoking to geographic disparities in adult mortality. We simultaneously
evaluate the robustness of the PGW indirect estimation technique and identify smoking as a key
factor determining regional variation in adult mortality within the United States.
The key substantive pattern we attempt to explain is the Southern mortality disadvantage
relative to other regions. Among women, smoking-related mortality is responsible for 23% of
the South’s disadvantage relative to the rest of the country and 35% of its excess relative to the
Mountain region. For men, it explains 50% of the South’s excess mortality relative to the rest of
the US and 60% of the disparity with the Mountain region. Given the lag in the relation between
smoking and mortality, these disparities reflect both historical and contemporary state-to-state
differences in smoking behavior.
Such persistent differences in the burden of smoking across states to some extent reflect
local tobacco policy environments and cultures surrounding smoking. Since the mid 1990s, state
tobacco control programs have been rather effective at promoting smoking cessation and
preventing others from taking up the habit (Cokkinides et al. 2009; Farrelly et al. 2008).
Statewide workplace smoking bans may be beneficial not just for individuals at work, but also
for the acceptability of smoking in the state context (Farrelly, Evans and Sfekas 1999). Indeed,
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states with no statewide smoking ban show a higher prevalence of smoking compared with those
states banning smoking from all workplaces (CDC 2005, 2010). Along with smoking bans,
cigarette excise taxes may also be an important factor in determining local tobacco cultures and
are likely to be key policy interventions responsible for declines in cigarette consumption
(Franks et al. 2007; Pierce et al. 2010). States vary widely in the amount of per-pack tax levied
on cigarettes, from less than $0.25 to more than $4.00, which produce large differences in the
price of a pack of cigarettes (CDC 2010). However, the correlation between tax level and
smoking prevalence appears to be relatively weak (CDC 2010).
Estimating mortality attributable to cigarette smoking is important for informing public
health policies aimed at limiting avoidable deaths. Direct methods, such as that used by the
CDC, require extensive data collection, make numerous assumptions about the impact of
smoking on mortality, and are subject to a variety of potential biases. The use of lung cancer
mortality as the indicator of damage from smoking bypasses many of the attendant
difficulties.We have provided a set of estimates of the impact of smoking using lung cancer
morality and its empirical correlation with other causes of death. This correlation was estimated
based exclusively on interstate data in the US. Results suggest that smoking is continuing to play
a major role in the level of and regional variation in American mortality.
In the course of this investigation, we have estimated the parameters of a model proposed
by Preston, Glei and Wilmoth on an entirely new data set than the one that they employ. We find
that the relation between lung cancer mortality and mortality from other causes of death is
remarkably similar for males across 50 states of the United States to the one they identify across
21 countries. For women, however, a unit change in lung cancer mortality is associated at most
ages with a smaller increment in other causes of death when estimated on data for US states than
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when estimated on international data. We believe that this difference reflects a greater maturity
of the smoking epidemic in the contemporary US than in the sample of countries on which the
international estimates were based. Accordingly, we suggest that the coefficients estimated here
are more appropriate for countries like the US where smoking has been pervasive for many
decades.
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Table 1: Estimated coefficients for lung cancer death rate by age and sex
Age
50-54
55-59
60-64
65-69
70-74
75-79
80-84

Male
0.297
0.186
0.111
0.073
0.046
0.027
0.016

Female
0.207
0.175
0.087
0.085
0.069
0.056
0.039

Estimated using negative binomial regression in Equation (1). Includes controls and age interactions. The
exponential of the above coefficients represents the proportional increase in the death rate for other causes
associated with a one-per-thousand increase in the lung cancer death rate.
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Table 2: Age-specific lung cancer death rates (per 1,000)

Age
50-54
55-59
60-64
65-69
70-74
75-79
80-84
1From

Observed (2004)
Male
Female
0.31
0.50
0.61
0.96
1.13
1.80
1.75
2.86
2.39
4.01
2.75
5.08
2.80
5.31

Lifelong nonsmokers1
Male
Female
0.06
0.06
0.05
0.07
0.12
0.12
0.22
0.17
0.35
0.31
0.52
0.33
0.89
0.58

Thun et al. (1997) for death rates of never smokers in the Cancer Prevention Study, Cohort II
1982 - 1988.
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Table 3: Contribution of Smoking to Southern Mortality Disadvantage
Fraction of difference in all-cause mortality
due to smoking in 2004
Women

Men

Pacific1

17.6%

47.3%

Mountain2

35.5%

60.0%

Upper Midwest3

24.5%

42.8%

Central Midwest4

18.1%

47.5%

Northeast5

20.0%

50.2%

All non-Southern states

23.3%

50.3%

Regional Comparison

Note: Refers to death rate ages 50+ standardized to the 2000 U.S. population.
Southern states considered are: Alabama, Arkansas, Georgia, Kentucky,
Louisiana, Mississippi, Tennessee, West Virginia
1Alaska,

California, Hawaii, Oregon, Washington

2Arizona,
3Iowa,

Colorado, Idaho, Montana, New Mexico, Utah, Wyoming

Minnesota, North Dakota, South Dakota, Wisconsin

4Illinois,

Indiana, Michigan, Ohio
Maine, Massachusetts, New Hampshire, New Jersey, New York,
Rhode Island, Vermont

5Connecticut,
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Table 4: Mortality attributable to cigarette smoking in the U.S.:
A comparison of estimates
Females
Males
2000 2004
2000 2004
Current Model1
0.17
0.17
0.22
0.21
Preston, Glei, Wilmoth (2010)2
0.19
0.2
0.23
0.22
3
Rostron (2010)
0.14
―
0.22
―
Peto-Lopez4
0.21
―
0.24
―
5
*
CDC Method
―
0.15
―
0.23*
Rogers6
0.13†
―
0.21†
―
1Coefficient
2

estimates across 50 U.S. states using negative binomial regression, ages 50-84

Estimates pertain to ages 50-84 across countries using negative binomial regression

3Ages

50+ based on negative binomial regression including age-period interaction term

4Ages

35+. Peto-Lopez estimates from (http://www.ctsu.ox.ac.uk/deathsfromsmoking)

5Estimates
6Figures

reported by the Centers for Disease Control and Prevention (2008), ages 35+

reported in Rogers et al. (2005) for the year 2000, ages 35+

†

Estimates pertains to ages 35+ in 2000

*

Estimates based on data for the period 2000-2004
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Table A.1: Estimated attributable fraction by state: 2004
Female
Alabama
0.16
(0.143,0.180)
Alaska
0.23
(0.207,0.248)
Arizona
0.16
(0.142,0.179)
Arkansas
0.20
(0.176,0.221)
California
0.15
(0.133,0.168)
Colorado
0.14
(0.125,0.156)
Connecticut
0.17
(0.149,0.189)
Delaware
0.21
(0.189,0.235)
Florida
0.18
(0.161,0.200)
Georgia
0.16
(0.139,0.175)
Hawaii
0.13
(0.113,0.138)
Idaho
0.15
(0.128,0.163)
Illinois
0.17
(0.153,0.192)
Indiana
0.18
(0.159,0.199)
Iowa
0.17
(0.148,0.184)
Kansas
0.17
(0.147,0.187)
Kentucky
0.22
(0.200,0.247)
Louisiana
0.18
(0.159,0.201)
Maine
0.20
(0.179,0.224)
Maryland
0.18
(0.159,0.200)
Massachusetts
0.18
(0.160,0.202)
Michigan
0.18
(0.163,0.205)
Minnesota
0.17
(0.150,0.186)
Mississippi
0.17
(0.152,0.190)
Missouri
0.19
(0.172,0.215)
Montana
0.20
(0.177,0.224)
Nebraska
0.14
(0.122,0.152)
Nevada
0.22
(0.194,0.245)
New Hampshire
0.20
(0.175,0.221)
New Jersey
0.17
(0.149,0.190)
New Mexico
0.12
(0.110,0.138)
New York
0.16
(0.138,0.172)
North Carolina
0.17
(0.147,0.184)
North Dakota
0.13
(0.121,0.149)
Ohio
0.18
(0.163,0.206)
Oklahoma
0.18
(0.159,0.200)
Oregon
0.20
(0.176,0.222)
Pennsylvania
0.16
(0.144,0.184)
Rhode Island
0.18
(0.156,0.198)
South Carolina
0.15
(0.135,0.169)
South Dakota
0.15
(0.131,0.162)
Tennessee
0.19
(0.164,0.206)
Texas
0.16
(0.143,0.180)
Utah
0.07
(0.059,0.076)

Male
0.25
0.20
0.17
0.27
0.16
0.13
0.19
0.25
0.20
0.25
0.15
0.15
0.21
0.24
0.22
0.21
0.30
0.26
0.23
0.20
0.19
0.22
0.18
0.28
0.25
0.17
0.20
0.18
0.21
0.18
0.13
0.17
0.25
0.20
0.23
0.24
0.20
0.20
0.21
0.24
0.20
0.28
0.21
0.11

(0.242,0.269)
(0.191,0.211)
(0.164,0.184)
(0.255,0.283)
(0.149,0.167)
(0.127,0.143)
(0.182,0.204)
(0.236,0.264)
(0.199,0.216)
(0.238,0.263)
(0.146,0.162)
(0.142,0.158)
(0.203,0.227)
(0.224,0.252)
(0.206,0.231)
(0.200,0.224)
(0.281,0.312)
(0.248,0.275)
(0.216,0.243)
(0.189,0.211)
(0.179,0.203)
(0.205,0.228)
(0.172,0.193)
(0.268.0.296)
(0.241,0.269)
(0.163,0.185)
(0.190,0.214)
(0.175,0.195)
(0.195,0.218)
(0.169,0.190)
(0.125,0.140)
(0.166,0.185)
(0.235,0.261)
(0.190,0.215)
(0.215,0.242)
(0.229,0.255)
(0.185,0.208)
(0.189,0.213)
(0.201,0.226)
(0.232,0.257)
(0.193,0.218)
(0.263,0.292)
(0.195,0.217)
(0.102,0.114)
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Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
United States

0.16
0.18
0.19
0.19
0.16
0.14
0.17

(0.146,0.181)
(0.157,0.199)
(0.171,0.215)
(0.164,0.208)
(0.144,0.179)
(0.119,0.151)
(0.151,0.188)

Note: 95% Confidence intervals in parentheses

0.19
0.22
0.19
0.25
0.20
0.15
0.21

(0.183,0.204)
(0.207,0.231)
(0.177,0.199)
(0.233,0.263)
(0.185,0.209)
(0.141,0.159)
(0.195,0.218)
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Figure 1: All-cause mortality and smoking prevalency by state: 2004
(a) Age-adjusted death rate, ages 50+, by state in 2004

Source: Author’s calculations from National Center for Health Statistics

(b)Percentage of adults who currently smoke cigarettes by state in 2004

Source: Centers for Disease Control and Prevention
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Figure 2: Age-specific lung cancer death rates for men and women in the United States in 2004
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Figure 3: State-specific smoking-attributable mortality by sex: 2004
Females

Males

39
Figure 4: Comparability of Attributable fraction based on our estimates and CDC across 50 states
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Figure 5: Estimated model coefficients based on the current model and Preston, Glei, and Wilmoth
(2010)
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